raytayzmd

Vanda Pharmaceuticals: Tomorrow's Headline Stock

....you do?...brother, you've got no business giving investment advice.

On May 07 11:15 PM Joe Kunkle wrote:

> I expect the 2 Wall St Analysts uprading shares to Buy today did
> plenty of homework. Check back in a month.

Vanda Pharmaceuticals: Tomorrow's Headline Stock

...one can only hope the Lord will have mercy on the ignorant...do your homework, son...ilioperidone is just a variant of respiridone, otherwise known as risperdal...risperdal has been around like 15 years and is already marketed as a generic...Hoechst Marion dumped ilioperidone onto Titan Pharmaceutical 13 years ago...Titan sold international rights to Novartis in 1998 and Novartis didn't do anything with it...Titan messed with it for a while but apparently realized what a waste of effort it was and sold it to VNDA in 2002...ostensibly, VNDA's chairman had some of genotype test that would allow him to identify patients on whom ilioperidone MIGHT work better...at one point there were several lawsuits being bounced around about the drug but I don't know whatever happened to those...if you want to know VNDA's real potential ask your family MD...tasimelteon???...... more than a variant of the currently available rozarem...the funny thing is that rozerem has never been shown to be any more safe OR effective than just taking plain old melatonin!...so VNDA successfully develops yet another drug that no one needs -- whoopee!...VNDA is nothing more than a stupid Wall Street trick that was probably never meant to do more than enrich some venture capitalists and company management at the expense of naieve investors.

U.S. Prescription Drug Sales Grow Slowly; Hydrocodone Most Prescribed

....$291.5 billion for anti-psychotics??...da... say we bring back lobotomies!...every bit as effective...and almost as simple -- just need a kitchen table, an ice pick, and a hammmer!

The 'Reflation' Top Ten Portfolio

...BNA????...BNA is a CEF trading at par with its NAV and yielding less than 7% with an expense ratio somewhere around 4%...you consider that worthy of a top ten list???...compare JGG trading at a discount of 11%, yielding 10%, and with an expense ratio of 1% and pretty much holding the same stuff as BNA...pardon me if I don't hire you as a financial advisor.

More Biotech Layoffs: Bristol-Myers Squibb, Entremed Feel the Pain

...how appropriate that after an article mentioning one scam biotech -- ENMD -- someone should come along and ask a question -- aka "pump" -- another scam biotech -- MRNA...MRNA used to be "Nastech Pharmaceutical" and claimed to be developing a system for delivering drugs using a nasal spray...when the suckers stopped lining up for that "dog and pony show" they changed their name and -- voila! -- they are now in the RNAi drug development business...they only have about 10 million in cash and given current economic circumstances will unlikely be able to con anyone else out of any dough...so with any luck at all maybe we'll FINALLY see them go belly up!...one can only hope!